PML/RAR alpha APL with undifferentiated morphology and stem cell immunophenotype

Evaluation of infectious complications in patients with myelodysplastic syndromes: a prospective cohort study from the Canadian MDS registry.

Annals of hematology·2024

Feasibility of collecting longitudinal patient-reported outcomes in individuals with relapsed or refractory large B-cell lymphoma who received chimeric antigen receptor T-cell (CART) therapy.

BMC cancer·2024

Cardiovascular events among recipients of hematopoietic stem cell transplantation-A systematic review and meta-analysis.

Bone marrow transplantation·2023

Home and nearby nature: Uncovering relational flows between domestic and natural spaces in three countries during COVID-19.

Wellbeing, space and society·2022

First-line therapy, autologous stem-cell transplantation, and post-transplantation maintenance in the management of newly diagnosed mantle cell lymphoma.

Current oncology (Toronto, Ont.)·2020

Canadian perspective on managing multiple myeloma during the COVID-19 pandemic: lessons learned and future considerations.

Current oncology (Toronto, Ont.)·2020

DNA methylation signatures distinguish extranodal NK/T-cell lymphoma and EBV-positive nodal T/NK-cell lymphoma and identify prognostic subgroups.

Leukemia·2026

EIF4A3-dependent nonsense-mediated decay buffers AML1-ETO9a dosage and modulates outcome in t(8;21) acute myeloid leukemia.

Leukemia·2026

Mutational profile and cardiovascular risk factors impact prognosis in triple-negative essential thrombocythemia.

Leukemia·2026

PLK1 inhibition enhances Brentuximab vedotin efficacy in CD30-positive T-cell lymphoma via spindle assembly checkpoint activation.

Leukemia·2026

Randomized phase 2 trial of CPX-351 vs. CLAG-M (cladribine, cytarabine, G-CSF, and mitoxantrone) for medically unfit adults with acute myeloid leukemia or other high-grade myeloid neoplasms.

Leukemia·2026

Mantle cell lymphoma artificial intelligence prognostic index using hematoxylin and eosin histology.

Leukemia·2026

Multivalence Aptamers Enhance Transmembrane Efficiency of Localized Catalytic Hairpin Assembly-Based Nanomachine for Sensitive Cell Imaging.

Analytical chemistry·2026

Exploiting amino acid-modulated active sites of Cu-MOF nanozyme for signal-amplified electrochemical aptasensing of cardiac troponin I.

Mikrochimica acta·2026

Misfortune Begets Fortune? Tailoring Facets in the MXene Oxidation Process for a Sensitive and Recyclable SERS Platform.

Nano letters·2026

N4-acetylcytidine modification bridges metabolic reprogramming and immune evasion in cancer: mechanisms and therapeutic implications.

Frontiers in immunology·2026

Boosting the vascularization and regenerative capacity of nanofat by short-term ex vivo pretreatment with erythropoietin.

Journal of translational medicine·2026

Ligand-Mediated Reprogramming Redirects Liver-Tropic Ionizable Lipid Nanoparticles for Lung-Selective mRNA Delivery.

Angewandte Chemie (International ed. in English)·2026

Related Experiment Videos

PML/RAR alpha APL with undifferentiated morphology and stem cell immunophenotype

Related Concept Videos

Evaluation of infectious complications in patients with myelodysplastic syndromes: a prospective cohort study from the Canadian MDS registry.

Feasibility of collecting longitudinal patient-reported outcomes in individuals with relapsed or refractory large B-cell lymphoma who received chimeric antigen receptor T-cell (CART) therapy.

Cardiovascular events among recipients of hematopoietic stem cell transplantation-A systematic review and meta-analysis.

Home and nearby nature: Uncovering relational flows between domestic and natural spaces in three countries during COVID-19.

First-line therapy, autologous stem-cell transplantation, and post-transplantation maintenance in the management of newly diagnosed mantle cell lymphoma.

Canadian perspective on managing multiple myeloma during the COVID-19 pandemic: lessons learned and future considerations.

DNA methylation signatures distinguish extranodal NK/T-cell lymphoma and EBV-positive nodal T/NK-cell lymphoma and identify prognostic subgroups.

EIF4A3-dependent nonsense-mediated decay buffers AML1-ETO9a dosage and modulates outcome in t(8;21) acute myeloid leukemia.

Mutational profile and cardiovascular risk factors impact prognosis in triple-negative essential thrombocythemia.

PLK1 inhibition enhances Brentuximab vedotin efficacy in CD30-positive T-cell lymphoma via spindle assembly checkpoint activation.

Randomized phase 2 trial of CPX-351 vs. CLAG-M (cladribine, cytarabine, G-CSF, and mitoxantrone) for medically unfit adults with acute myeloid leukemia or other high-grade myeloid neoplasms.

Mantle cell lymphoma artificial intelligence prognostic index using hematoxylin and eosin histology.

Multivalence Aptamers Enhance Transmembrane Efficiency of Localized Catalytic Hairpin Assembly-Based Nanomachine for Sensitive Cell Imaging.

Exploiting amino acid-modulated active sites of Cu-MOF nanozyme for signal-amplified electrochemical aptasensing of cardiac troponin I.

Misfortune Begets Fortune? Tailoring Facets in the MXene Oxidation Process for a Sensitive and Recyclable SERS Platform.

N4-acetylcytidine modification bridges metabolic reprogramming and immune evasion in cancer: mechanisms and therapeutic implications.

Boosting the vascularization and regenerative capacity of nanofat by short-term ex vivo pretreatment with erythropoietin.

Ligand-Mediated Reprogramming Redirects Liver-Tropic Ionizable Lipid Nanoparticles for Lung-Selective mRNA Delivery.

Related Experiment Videos

PML/RAR alpha APL with undifferentiated morphology and stem cell immunophenotype

Related Concept Videos

Related Articles